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Abstract
Background: A deficiency in Perk (EIF2AK3) causes multiple neonatal defects in humans known
as the Wolcott Rallison syndrome. Perk KO mice exhibit the same array of defects including
permanent neonatal diabetes (PND). PND in mice was previously shown by us to be due to a
decrease in beta cell proliferation and insulin secretion. The aim of this study was to determine if
acute ablation of PERK in the 832/13 beta cells recapitulates these defects and to identify the
primary molecular basis for beta cell dysfunction.
Results: The INS1 832/13 transformed rat beta cell line was transduced with a dominant-negative
Perk transgene via an adenoviral vector. AdDNPerk-832/13 beta cells exhibited reduced expression
of insulin and MafA mRNAs, reduced insulin secretion, and reduced cell proliferation. Although
proinsulin content was reduced in AdDNPerk-832/13 beta cells, proinsulin was abnormally retained
in the endoplasmic reticulum. A temporal study of the acute ablation of Perk revealed that the
earliest defect seen was induced expression of two ER chaperone proteins, GRP78/BiP and ERp72.
The oxidized states of ERp72 and ERp57 were also increased suggesting an imbalance in the redox
state of the ER.
Conclusion: Acute ablation of Perk in INS 832/13 beta cells exhibited all of the major defects seen
in Perk KO mice and revealed abnormal expression and redox state of key ER chaperone proteins.
Dysregulation of ER chaperone/folding enzymes ERp72 and GRP78/BiP occurred early after
ablation of PERK function suggesting that changes in ER secretory functions may give rise to the
other defects including reduced insulin gene expression, secretion, and cell proliferation.
Background
Monogenic forms of permanent neonatal diabetes have
revealed key aspects of the development and function of
the insulin secreting beta cells [1]. Mutations in Perk
(EIF2AK3) underlies the complex genetic disorder of the
Wolcott Rallison syndrome, which includes permanent
neonatal diabetes (PND), exocrine pancreas deficiency,
growth retardation, hepatic dysfunctions, and skeletal
dysplasias [2,3]. All of the dysfunctions in WRS are mir-
rored in mice deficient for PERK [4,5], and detailed
genetic studies in mice have shown that the diabetes is
caused by the loss of expression of PERK in the insulin
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secreting beta cells [6], whereas the exocrine pancreas
deficiency is caused by the absence of PERK in the pancre-
atic acinar cells [7]. The initial interpretation of the molec-
ular basis of these dysfunctions in humans and mice was
based upon studies performed in vitro with cultured
fibroblasts [8]. These studies showed that the catalytic
domain of PERK resides in the cytoplasm where it phos-
phorylates the translation initiation factor eIF2 alpha,
which results in either repression of global protein synthe-
sis or activation of translation of specific mRNAs encod-
ing gene regulatory proteins. PERK regulatory domain
resides in the lumen of the ER and is controlled by the
binding of the ER chaperone proteins, GRP78/BiP and
GRP94, and calcium [9]. Disturbances in the ER such as
ER stress and accumulation of unfolded proteins, or nor-
mal physiological changes in calcium levels can activate
PERK [9,10]. Based upon these studies it was proposed
that PND in humans and mice deficient in PERK was
caused by uncontrolled ER stress and apoptotic cell death
of the beta cells [11]. However a recent comprehensive
analysis of the islet and beta cell development revealed
that the cause of diabetes in Perk deficient mice is due to
failure to expand beta cell mass and defects in beta cell
development and insulin secretion during the critical fetal
and neonatal periods [6]. Thus three distinct defects are
seen in Perk-deficient beta cells, which raises questions
about the causal connection and progression of beta cell
dysfunction. The chronic loss of PERK expression over the
four-week period between when defects in beta cell devel-
opment are first seen during the fetal stage and the onset
of overt diabetes three weeks after birth confounds resolv-
ing these questions and determining the molecular basis
of the defects in Perk-deficient mice. To investigate the
acute effects of PERK ablation we have expressed a domi-
nant negative mutation of Perk in the transformed INS1
832/13 beta cell line. We found that acute ablation of
PERK in 832/13 beta cells mimics all of the defects seen in
the beta cells of Perk-deficient mice and detailed temporal
studies suggest that defects in the function of the endo-
plasmic reticulum may give rise to the defects in beta cell
developmental and proliferation.
Results
Ablation of PERK in INS1 832/13 beta cells results in 
reduced insulin gene expression, insulin content, and 
insulin secretion
To investigate the acute effects of ablating PERK expres-
sion, the transformed rat INS 832/13 insulin-secreting
beta cells [12] were transduced with a dominant negative
mutant of Perk using the adenoviral vector (AdDNPerk)
yielding  AdDNPerk-832/13 beta cells. The AdDNPerk
transgene contains a C-terminal truncation of the kinase
domain of mouse Perk [13] tagged with c-myc which was
inserted into an adenoviral vector that contains a GFP
marker to monitor transduction efficiency. An adenoviral
vector expressing the E. coli lacZ (β-galactosidase) denoted
AdLacZ  was used throughout as a control. After 24-48
hours post-transduction of AdDNPerk, greater than 90%
of the 832/13 beta cells were successfully transduced as
shown by expression of the GFP marker (not shown). The
DNPERK protein was detected (Figure 1A) in transduced
832/13 beta cells, and significantly ablated the activity of
the endogenous PERK as shown by reduced levels of phos-
phorylated eIF2 alpha (Figure 1A). Ablation of PERK
resulted in a significant reduction of the insulin-1, insulin-
2, MafA, and Glut2 mRNAs while the expression of other
important genes in beta cell development and function
including  Pdx-1,  NeuroD, and Gck  were nearly normal
(Figure 1B). In parallel to decreased Insulin-1 and Insulin-
2 mRNA expression, insulin content per beta cell was sig-
nificantly reduced as a function of the dose of DN-PERK
transduced in the 832/13 beta cells (Figure 2A, B) mirror-
ing the reduced insulin content of the pancreatic islets of
Perk KO mice [6].
Islets isolated from neonatal Perk KO mice exhibited an
almost complete ablation of glucose-stimulated insulin
secretion (GSIS) [6]. To determine if an acute deficiency of
PERK impacts insulin secretion, 832/13 beta cells were
transduced with AdDNPerk. Forty-eight hours post-trans-
duction of AdDNPerk-832/13 cells showed a 3-fold reduc-
tion in insulin secretion in response to 15 mM glucose
stimulation compared to 832/13 transduced with the
AdLacZ control (Figure 2C). Treatment of AdDNPerk-832/
13 cells with tolbutamide, a KATP channel blocker, also
showed reduced enhancement of glucose stimulated insu-
lin secretion compared to the control cells. Treatment
with diazoxide, a KATP channel opener, blocked glucose-
stimulated insulin secretion (Figure 2D) in both geno-
types as expected. We conclude that the reduced GSIS is
due to a combination of decreased insulin content as well
from a partial reduction in KATP-dependent insulin secre-
tion.
Proliferation of AdDNPerk 832/13 beta cells is reduced
The cell proliferation rate of AdDNPerk-832/13 and LacZ-
832/13 beta cells was estimated by BrdU incorporation.
AdDNPerk-832/13 exhibited a 25% reduction in prolifer-
ation compared to AdLacZ-832/13, consistent with a gen-
eral observation of the relative growth rates of these cells
across several independent experiments (Figure 3A). Cell
death, estimated as TUNEL positive cells, was low in both
genotypes and not significantly different from each other
(Figure 3B).
Accumulation of proinsulin in the ER occurs in the absence 
of increased protein synthesis in Perk deficient beta cells
Proinsulin is co-translationally imported into the endo-
plasmic reticulum and rapidly enters the Golgi complex
[14,15] where it accumulates in beta cells prior to its mat-BMC Cell Biology 2009, 10:61 http://www.biomedcentral.com/1471-2121/10/61
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uration and formation of insulin secretory granules [6]. In
Perk KO mice, however, a large fraction (ca. 20-40%) of
the beta cells exhibited grossly distended endoplasmic
reticulum with a very high accumulation of proinsulin
[6]; these abnormal cells are denoted herein as Impacted-
ER beta cells. Acute ablation of PERK in 832/13 cells also
resulted in appearance of Impacted-ER cells as character-
ized by a shift of the majority of proinsulin from the Golgi
complex to the endoplasmic reticulum (Figure 4A). In
contrast we have not observed Impacted-ER cells in the
control AdLacZ-832/13 cells (Figure 4A) or in the pancre-
atic islets of wild-type mice (Figure 4B).
When PERK is highly activated by ER stress it represses
global protein synthesis [16,17], and it has been specu-
lated that the loss of PERK function may result in dere-
pressed protein synthesis and over accumulation of
proteins in the ER. Conversely, we found that global pro-
tein synthesis rates were not elevated in AdDNPerk-832/
13 cells (Figure 5A) and proinsulin content was reduced,
not increased (Figure 2B). Thus the over accumulation of
proinsulin in the ER is not due to over synthesis of proin-
sulin.
ERp72 and GRP78/BiP expression are induced first after 
initiating acute ablation of Perk followed by other 
changes in gene expression
To further explore the possible causes and consequences
of proinsulin retention in ER in Perk-deficient beta cells,
the expression of key ER chaperone, trafficking, ERAD
genes were examined in 832/13 cells that had been trans-
duced with a relatively low titer (10 MOI) of AdDNPerk
and in pancreatic islets isolated from neonatal (P1) Perk
KO mice. Using a lower titer of AdDNPerk, Ins1, Ins2, and
Glut2 were expressed at normal levels (Figure 6), unlike
that seen at high titers (Figure 1B) and Perk KO islets
where these genes were significantly repressed compared
to control. MafA  mRNA was significantly repressed in
both AdDNPerk-832/13 and Perk KO islets. The ER chap-
erone genes ERp72  and  GRP78/BiP  were substantially
induced while most other ER chaperones (ERp58, ERp57,
Ero1β, and Ero1L) and ERAD associated (Psma5, Sec61a,
Sec63, and Der1) genes were not significantly elevated
(Figure 6). To determine the temporal pattern of the
induction of these genes following acute ablation of Perk,
the mRNA level of several genes was assessed at various
time points after transduction of 832/13 beta cells with
AdDNPerk (Table 1). Ins1, Ins2, and MafA were not signif-
icantly reduced until 36 hours after transduction, whereas
ERp72 and GRP78/BiP were induced after only 16 hours.
The beta cells of Perk KO mice showed reduced expression
of several cell-cycle and proliferation genes associated
with a substantial reduction in beta proliferation [6]. Cyc-
lin A and cyclin D mRNAs were also reduced in AdDNPerk-
832/13 beta cells but not until 48 hours. The splicing of
Xbp-1  mRNA is a sensitive indicator of the ER stress
response, and the over accumulation of proinsulin is pre-
dicted to elicit and an ER stress response, but surprisingly
Expression of AdDNPerk in 832/13 cells down-regulates insulin mRNA levels Figure 1
Expression of AdDNPerk in 832/13 cells down-regulates insulin mRNA levels. A. Expression of DNPERK was 
detected by tag c-myc antibody and the eIF2α [P]/total eIF2α was reduced when two different multiplicities of infection were 
used. (MOI of AdLacZ1 and AdDNPerk1 = 10; MOI of AdLacZ2 and AdDNPerk2 = 20). B. At 48 hr post-transduction, the expres-
sion of insulin gene, MafA, NeuroD, and Glu2 was significantly reduced in AdDNPerk-832/13 cells. The data are expressed rela-
tive to the AdLacZ-832/13 (= 100%) ± SE, n = 4. *P < 0.05, **P < 0.01, ***P < 0.001.
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neither beta cells in Perk deficient mice or AdDNPerk-832/
13 beta cells showed increased splicing of Xbp-1 mRNA
(Figure 6). Increased expression of ERp72 in AdDNPerk-
832/13 cells was also seen by immunohistochemistry ear-
lier than the appearance of the Impacted-ER cells (Figure
4A). We further tested the hypothesis that unrepressed
global protein synthesis is responsible for the induction of
the ER chaperones ERp72  and  GRP78/BiP  by treating
AdDNPerk-832/13 beta cells with cyclohexamide, a potent
inhibitor of protein synthesis. Cyclohexamide did not
block the induction of ERp72 and GRP78/BiP in AdDN-
Perk-832/13 beta cells (Figure 5B) and did not reduce or
delay the appearance of Impacted-ER beta cells (data not
shown) thus arguing against this hypothesis.
ERp72 and GRP78/BiP are induced by the transcription
factor ATF6 [18]. Although we could not readily detect the
active nuclear form of ATF6 in 832/13 beta cells (not
shown), we examined the processing of ATF6 in the
human embryonic kidney AD293 cell line co-transfected
with plasmids bearing ATF6 and DNPerk or vector control
and treated with DTT, an ER stress inducer. As expected,
ATF6 processing was induced by DTT in control cells (Fig-
ure 7). However, in AD293 cells transfected with DNPerk,
Ablation of PERK by AdDNPerk in 832/13 cells results in reduced insulin and proinsulin content and impaired insulin secretion Figure 2
Ablation of PERK by AdDNPerk in 832/13 cells results in reduced insulin and proinsulin content and impaired 
insulin secretion. A. At 48 hr post-transduction, insulin content was assayed by ELISA in cells infected with AdDNPerk and 
control virus at 5, 10 and 20 MOI. The data were normalized to DNA content. B. Proinsulin content was assayed by ELISA and 
normalized to DNA content. C. Insulin secretion in response to 3 and 15 mmol/l glucose was measured in cells infected with 
recombinant virus at 5, 10 and 20 MOI. D. Insulin secretion in response to 3 and 15 mmol/l glucose with or without 200 μmol/
l tolbutamide or 250 μmol/l diaxoxide. Insulin secretion in response to 15 mM glucose in C and D was normalized to total 
insulin content, and was expressed as a fold increases relative to insulin secreted from the control AdLacZ-832/13 cultured in 3 
m mol/l glucose. Values are means and error bars are ± SE, n = 3, *p < 0.05.BMC Cell Biology 2009, 10:61 http://www.biomedcentral.com/1471-2121/10/61
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the processed nuclear form of ATF6 was present at rela-
tively high levels in untreated cells and not further
induced by DTT. As new protein synthesis is not required
for the induction of ERp72 and BiP mRNA expression fol-
lowing acute ablation of Perk, post-translational process-
ing of ATF6 to its active nuclear form is consistent with the
hypothesis that ATF6 is responsible for their induction.
ERp72 protein expression and oxidized state is increased 
in PERK-ablated 832/13 cells
ERp72, a family member of the protein disulfide isomer-
ases (PDI), is localized in the ER and plays a major role in
quality control and folding [19-22]. These PDI enzymes
are particularly important for ER client proteins such as
proinsulin that depend upon cysteine disulfide bonds for
their folded structure. Indeed we have found that ERp72
was physically associated with proinsulin in 832/13 cells
(data not shown). As seen for ERp72 mRNA levels, ERp72
protein was elevated in AdDNPerk-832/13 beta cells and
similar increases were seen for GRP78/BiP (Figure 8A). In
Perk KO mice we found that the amount of ERp72 was ele-
vated (Figure 8B) and became localized to large balloon-
like structures in Impacted-ER cells (Figure 4B). Compari-
son of the ERp72 localization seen in IHC images (Figure
4B) to TEM images of Impacted-ER beta cells [6] suggest
that these structures correspond to one of two types of dis-
tended ER most similar to Russell bodies [23,24]. These
ERp72 enriched structures were rarely observed in the
AdDNPerk-832/13 cells.
The redox state of the PDI family of ER folding enzymes
including ERp72 and ERp57 is known to vary according to
changes in the oxidative and functional states of the ER. In
addition to increased levels of ERp72 protein, AdDNPerk-
832/13 beta cells exhibited an increase in the oxidized iso-
forms of ERp72 and ERp57 (Figure 8C) that were first seen
at 24 hours post transduction and increased significantly
by 36 hours.
Discussion
Despite the vast differences between the milieu and
ontogeny of cultured beta cells and native beta cells in the
endocrine pancreas, we found that the array of defects in
the beta cells of Perk KO mice [6] were remarkably present
following acute ablation of Perk in the transformed rat
INS1 832/13 beta cells. These defects include reduced cell
proliferation (without changes in cell death), reduced
expression of proinsulin and insulin, reduced glucose-
stimulated insulin-secretion, and abnormal retention of
proinsulin in the ER leading some cells to have a highly
distended ER. That these defects underlie the cause of neo-
natal diabetes in Perk KO mice, and by inference in
humans with the Wolcott Rallison syndrome, was shown
by the study of tissue-specific Perk KO mice and the ability
of a beta cell specific-Perk transgene to rescue diabetes
[6,7,25]. Given the close correspondence of cellular
pathology of the AdDNPerk-832/13 beta cells to the beta
cells of Perk KO mice, we were encouraged to take advan-
tage of cultured beta cells to elucidate the molecular func-
tion of PERK in regulating beta cell development and
physiology.
Acute ablation of Perk, afforded by transduction of the
dominant negative Perk transgene, allowed us to deter-
mine the progress and order of the ensuing defects over
time. As we had seen in Perk KO mice, the expression of
Ablation of PERK in 832/13 cells impairs beta cell proliferation but does not increase cell death Figure 3
Ablation of PERK in 832/13 cells impairs beta cell proliferation but does not increase cell death. A. BrdU incorpo-
ration is significantly reduced in cells infected with AdDNPerk at 24 hr post-transduction cells compared to AdLacZ infected 
cells. The data represent two thousand cells for each treatment in two independent experiments (*p < 0.05). B. Cell Death. 
The percentage TUNEL-positive 832/13 cells infected with the AdDNPerk was low and was not significantly different than the 
cells infected with the AdLacZ control. A MOI of 20 was used for these experiments.
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Ablation of PERK resulted in abnormal accumulation of proinsulin and ERp72 in beta cells Figure 4
Ablation of PERK resulted in abnormal accumulation of proinsulin and ERp72 in beta cells. A. At 48 hr post-trans-
duction, some of AdDNPerk-infected 832/13 cells had abnormal accumulation of proinsulin in the ER (upper panel, left arrow). 
ERp72 is upregulated in cells infected with AdDNPerk and the increase in ERp72 staining appeared earlier than the Impacted-ER 
phenotype (upper panel, right arrow). In contrast, cells infected with the AdLacZ-832/13 control exhibited normal Golgi locali-
zation of proinsulin (lower panel, arrow). B. ERp72 is abnormally retained in Perk KO beta cells in neonatal P1 mice. Double 
staining for both proinsulin and ERp72 demonstrates higher expression of ERp72 in beta cells than in exocrine cells and other 
endocrine cells in both WT and KO. In KO cells the ERp72 antibody stains balloon-like structures (shown in the inset). The 
data represent three or more independent mice for each genotype.
Proinsulin/DAPI
AdDNPerk
AdLacZ
ERp72/ DAPI Proinsulin/ERp72/ DAPI
WT
Perk KO
Proinsulin/DAPI ERp72/ DAPI Proinsulin/ERp72/ DAPIBMC Cell Biology 2009, 10:61 http://www.biomedcentral.com/1471-2121/10/61
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insulin synthesis genes Ins-1, Ins-2, and MafA) and cell
cycle genes was reduced but the reduction in their expres-
sion lagged behind the induction of the ER chaperone
genes ERp72 and GRP78/BiP thus suggesting that a pertur-
bation in the ER may result in repression of genes
involved in beta cell function and proliferation. Initial
reports showing that loss of PERK function resulted in
neonatal diabetes in humans and mice [2,4,5] suggested
that the molecular defect was related to the function of
PERK in the regulation of the ER stress - Unfolded Protein
Response (UPR). Our extensive analyses of Perk-deficient
beta cells in mice [6] and in AdDNPerk-832/13 beta cells
in culture have not supported this hypothesis. The origi-
nal hypothesis assumed that global protein synthesis
would be derepressed as a direct consequence of the
absence of PERK, and that this would result in uncon-
trolled protein synthesis and overloading of the ER culmi-
nating in apoptotic cell death [4]. Although the ER in Perk-
deficient beta cells show marked accumulation of proin-
sulin, we found that global protein synthesis was not ele-
vated nor was there an elevation in the proinsulin content
in beta cells. Cell death did not increase, but instead cell
proliferation was ablated. Moreover, the expression of
ERp72  and  GRP78/BiP  was still induced in AdDNPerk-
832/13 beta cells after blocking protein synthesis with
cyclohexamide suggesting that their induction was not
due to protein overload.
ERp72 and GRP78/BiP are positively regulated and insu-
lin gene expression is negatively regulated by ATF6
[18,26], and we found that the processed nuclear form of
ATF6 was substantially increased in PERK-ablated AD293
cells. Treatment of cells with Brefeldin-A also induces the
processing of the ATF6 [27], which is caused by relocaliza-
tion of the S2P protease from the Golgi to the ER. We
found that the S2P protease is indeed mislocalized in
PERK-ablated AD293 cells and is associated with ER
markers (Gupta, et al. unpublished data), which suggests
that the increased basal level of the nuclear form of ATF6
is due to mislocalization of the proteases that cleave pre-
cursor ATF6 rather than by ER stress. Further studies are
required to confirm the importance of these findings in
insulin-secreting beta cells.
Global protein synthesis in normal following acute ablation of PERK Figure 5
Global protein synthesis is normal following acute ablation of PERK. A. Incorporation of 35S translabel into total 
TCA-precipitable protein did not differ between AdDNPerk-infected and AdLacZ-infected cells at 24 hr (A) or 16 hr post-trans-
duction (data not shown). Values are means ± SE from three replicate samples. B. Cyclohexamide (CHX) did not inhibit the 
induction of ERp72 and BiP mRNA in AdDNPerk-infected 832/13 cells. At 12 hr post-transduction, cells were treated with 5 
mg/ml CHX for 4 hours before RNA was extracted for Real-time quantitative RT-PCR. Values are means ± SE, from three rep-
licate samples.
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Table 1: Temporal Changes in gene expression following Perk 
ablation in 832/13 cells
6 hr 16 hr 36 hr 48 hr
Ins1&II 1.02 (0.00) 1.04 (0.07) 0.64 (0.05)* 0.63 (0.12)*
MafA1 0.91 (0.10) 0.81 (0.10) 0.49 (0.12)* 0.64 (0.14)*
ERp72 0.92 (0.12) 1.81 (0.16)* 2.66 (0.52)* 3.24 (1.10)*
BiP 1.08 (0.26) 2.04 (0.32)* 4.26 (1.25)* 2.29 (0.34)*
Xbp1-S/T 1.03 (0.04) 1.35 (0.22) 1.56 (0.11) 1.32 (0.19)
Cyclin A 1.03 (0.05) 0.91 (0.06) 0.93 (0.05) 0.74 (0.10)*
Cyclin D 1.22 (0.04) 1.05 (0.08) 1.07 (0.23) 0.85 (0.11)
The values represent the levels of specific mRNAs in AdDNPerk-
transduced cells normalized to AdLacZ-transduced controls as 
determined by real-time quantitative RT-PCR. Time points (hr) 
indicate hours after transduction. The data are the average of two to 
five independent experiments. * P < 0.05BMC Cell Biology 2009, 10:61 http://www.biomedcentral.com/1471-2121/10/61
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In addition to its role in repressing global protein synthesis
during ER stress, PERK positively regulates the translation of
ATF4, which in turn upregulates GADD153/CHOP
[8,28,29]. Mutations in these downstream genes, however,
do not lead to diabetes in mice, [6,7] thus arguing against the
hypothesis that diabetes associated with Perk deficiency is
related to the role of PERK in regulating the unfolded protein
response. Considerable evidence suggests that PERK is
important for mediating the ER stress response in adult beta
cells [11,30-32], but we argue that the primary function of
PERK in beta cells is to regulate beta cell development and
function during the fetal-neonatal period. Interestingly IRE1,
another mediator of the ER stress response, has also been
shown to have an important beta cell function by positively
regulating insulin biosynthesis [33].
We speculate that the Impacted-ER phenotype, character-
ized by gross distension of the endoplasmic reticulum and
abnormal retention of proinsulin observed in Perk-defi-
cient beta cells, represents the extreme manifestation of
ER dysfunction. The induction of ERp72 and GRP/78
mRNA expression is the first hint of ER dysfunction, and
is followed by increased levels of these proteins and the
oxidized isoform of ERp72 and ERp57. The increased oxi-
dized isoforms of ERp72 and ERp57 suggests that redox
state of the ER is abnormal or that the oxidation and
reduction of protein disulfides is imbalanced. The forma-
tion of disulfide bonds is essential for the proper folding
proinsulin and subsequent maturation of insulin [14].
The protein disulfide isomerase family including ERp72,
PDI, and ERp57, mediate their oxidative protein folding
functions by forming transient mixed disulfides with ER
client proteins [34,35] such as proinsulin. In addition to
catalyzing the proper folding of proteins in preparation
for transport from the ER to the Golgi, the PDI enzymes
participate in ER associated protein degradation (ERAD)
by reducing thiols of misfolded proteins in preparation
for retrotranslocation to the cytoplasm for proteosomal
degradation [20,34]. Recently Forster and colleagues [19]
have shown that ERp72 and PDI have opposing functions
in the ER. ERp72 assists proper protein folding whereas
PDI facilitates unfolding of misfolded proteins in prepara-
tion for proteosomal degradation. We propose that PERK
regulates the expression of key genes that encode ER redox
and protein folding functions in the insulin-secreting beta
cells during the dynamic metabolic changes that occur
during the developmental transitions through embryonic,
fetal, neonatal, and juvenile stages. PERK enzyme activity
is regulated through its ER luminal domain via binding of
GRP78/BiP complexed with calcium [36,37]. Physiologi-
cal changes in ER calcium modulate PERK activity [10] as
well as insulin secretion. The regulation of ER calcium is
coupled to the redox state of specific ER proteins includ-
ing SERCA, the major ER calcium pump [38]. We specu-
late that PERK acts as an ER calcium sensor that couples
ER functions of folding, quality control, and protein traf-
ficking that are intimately tied to the redox state of the ER
as a function of the dynamic changes in the physiological
Comparison of gene expression in Perk deficient islets and 832/13 transformed beta cells Figure 6
Comparison of gene expression in Perk deficient islets and 832/13 transformed beta cells. The expression of 
mRNAs in Perk-/- islets and AdDNPerk 832/13 beta cells were normalized to Perk+/+ islets and AdLacZ 832/13 beta cells, respec-
tively. For the 832/13 cells a low dose of adenovirus (MOI = 5) was used, and the data from 2 to 5 independent experiments 
were analyzed. For islets, mRNA expression was also quantified from 5-9 WT and 4-9 Perk KO mice. For Xbp-1 the spliced 
Xpb-1 mRNA form was normalized to total Xbp-1 mRNA. Not assayed for specific mRNAs denoted as n.a.
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environment of the beta cell during the early developmen-
tal transitions.
Conclusion
We found that acute ablation of PERK in the transformed
832/13 beta cell line leads to reduced proliferation and
reduced insulin gene expression, insulin content, and
insulin secretion, demonstrating that acute ablation of
PERK recapitulates the major cellular and molecular
defects seen in Perk KO mice. In addition proinsulin accu-
mulates abnormally in the ER, which occurs after the ele-
vation of two key chaperone proteins GRP78/BiP and
ERp72. ERp72 accumulates in a sub compartment of the
ER and its oxidized isoform is substantially increased.
Because the changes in the expression of GRP78/BiP and
ERp72 are the earliest changes observed after ablation of
Perk, we suggest that ER dysfunctions give rise to defects in
proinsulin trafficking, insulin secretion, and cell prolifer-
ation.
Methods
Cell culture
INS-1 832/13 insulin-secreting beta cells were obtained
from Dr. Christopher Newgard (Duke University). The
832/13 cells were cultured in RPMI-1640 (Mediatech
Cellgro) supplemented with 11 mM glucose, 10% fetal
bovine serum, 10 mM HEPES, 1 mM sodium pyruvate, 50
μM β-mercaptoethanol and Antibiotic Antimycotic Solu-
tion (Sigma) at 37°C in 5% CO2, 95% air. The cells were
sub-cultured twice weekly. For determining relative prolif-
eration, BrdU (1 mM) was added to the cell for 1 hr fol-
lowed by permeabilization and fixation for 10 minutes
with 4% formaldehyde, 0.1% Triton x-100 in PBS. The
cells were then denatured with 1N HCL for 30 mins, and
anti-BrdU (1:50, DAKO) applied for 1 hour. For estimat-
ing cell death the DeadEndTM Fluorometric TUNEL Sys-
tem (Promega, Inc.) was used. Cells were fixed in 4%
methanol-free formaldehyde solution for 10 min, perme-
abilized with 0.2% Triton X-100 solution for 5 minutes,
and labeled according to instructions of the kit.
Proinsulin content, insulin content and insulin secretion
After 48 hr post-transduction, 832/13 cell pellets were
sonicated in 1 mol/l acetic acid containing 0.1% bovine
serum albumin. Aliquots of cell extracts were assayed for
proinsulin and insulin content using proinsulin EIA
(ALPCO) and Mouse Insulin Ultrasensitive EIA (ALPCO),
respectively. The data were normalized to DNA content.
Insulin secretion was assayed at 3 mmol and 15 mmol/l
glucose. For KATP channel dependent secretion assay, 200
μmol/l tolbutamide or 250 μmol/l diazoxide were added.
Plasmids and adenovirus production
The c-myc tagged dominant-negative mouse Perk trans-
gene (PERKΔC) was kindly provided by Dr. David Ron
(New York University). PERKΔC was generated by delet-
ing the kinase domain of Perk residing in the carboxy ter-
minal coding sequence, retaining the amino terminal ER
luminal domain (Harding, 1999). The PERKΔC transgene
was excised by us from the parent vector by digestion with
Spe1 and Xho1 and then inserted to the Adenovirus vector
pShuttle-IERS-hrGFP-1 (Stratagene). The resulting con-
struct, which we denote as AdDNPerk, was transfected into
AD-293 cells using the MBS Mammalian Transfection kit
(Stratagene) for amplification. The adenovirus was then
purified by Adeno-X™ Virus Purification kit (Clontech)
and the titer was determined by the QuickTiter™ Adenovi-
rus Titer Immunoasssay Kit (Cell Biolabs, Inc.). The
pShuttle-CMV-lacZ transgene, denoted herein as AdLacZ,
served as a control. Transduction of 832/13 cells was car-
ried out at a cell confluency of about 70%, at different
multiplicities of infection (MOI) from 5 to 20. A MOI of
20 was used in most experiments unless otherwise stated.
After 2 hours of incubation with the virus at 37°C, 5%
CO2, cells were washed once in RPMI and cultured for an
additional 6-48 h before assay.
To assess ATF6 processing the expression plasmid pCM-
Vshort-EYFP-ATF6-alpha, provided by Kazutoshi Mori,
was transfected into AD293 cells.
Mouse strains
The Perk knockout strain was previously generated by us
[5] and are congenic for C57BL/6J or 129SvEvTac. Both
congenic strains exhibited all of the beta cell defects previ-
ously described [5].
Islet isolation
The pancreata from E18.5 to p2 mice were inflated in situ
by injecting 3 mg/ml Collagenase P (Invitrogen) in HBSS
Basal levels of processed ATF6 are elevated in PERK-ablated  cells Figure 7
Basal levels of processed ATF6 are elevated in PERK-
ablated cells. AD293 cells were co-transfected with EYFP-
ATF6a and either empty vector or DNPerk. Each type of co-
transfection was treated with and without 5 mM DTT for 1 
hr. Immunoblotting with an antibody that recognizes tagged 
ATF6 shows both the ER-resident uncleaved and cleaved 
nuclear forms. Quantification of the nuclear ATF6 expressed 
as a percentage of the full-length form is shown below the 
tubulin panel.
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(Sigma) and digestion was carried out at 37°C for about
12 mins at which time 1 ml of ice-cold HBSS was added
to stop the enzyme reactions. The dispersed pancreatic tis-
sue was pelleted and washed once with HBSS. The pellets
were then suspended in 1 ml Histopaque-1077, overlaid
with 0.2 ml RPMI 1640 medium and centrifuged at 890 g
for 12 min to separate the islet from the other cell types
and residual debris. Islets were manually picked under a
dissection microscope and washed once with ice-cold
HBSS.
Gene expression levels
Quantification of gene expression was carried out by using
qPCR Core Kit for SYBR Green I (Eurogentec) amplifying
cDNA with the ABI Prism 7000 Sequence Detection System.
The following cycling conditions were used for all primer
pairs: 50°C (2 minutes), 95°C (10 minutes), 40 cycles of
(95°C [15 seconds], 60°C [1 minute]). Levels of Xbp1-s
(spliced form) were normalized to Xbp1-t (total) levels. All
other mRNAs were normalized to the levels of actin and/or
GAPDH. The mouse primer sequences were as follows: actin
5'-GCCCTGAGGCTCTTTTCC-3', 5'-TGCCACAGGATTC-
CATACCC-3'; GAPDH 5'-GGAGCGAGACCCCACTAACA-3',
5'-ACATACTCAGCACCGGCCTC-3'; Insulin I 5'-
AGCATCTTTGTGGTCCCCAC-3', 5'-CCCCACACACCAGG-
TAA-3'; Insulin II 5'-CAGAAGCGTGGCATTGTAGA-3', 5'-
TTGCAGTAGTTCTCCAGCTGG-3'; MafA, 5'-GCTGGTATC-
CATGTCCGTGC-3', 5'-GTCGGATGACCTCCTCCTTG-3';
Pdx-1, 5'-GAGCGTTCCAATACGGACCA-3',5'-TCAGCCGT-
TCTGTTTCTGGG-3'; ERP72, 5'-TTCCACGTGATGGATGT-
TCAG-3', 5'-AGTCTTACGATGGCCCACCA-3'; ERP57, 5'-
GGCGGATGCAACATATCACC-3', 5'-TGTGGTTCGTACT-
GTCCCCC-3'; ERP58, 5'-CAAGAGGCTTGCCCCTGAG-3', 5'-
GGTGTTTGTGTTGGCAGTGC-3'; Hrd1, 5'-TGGCTTTGAG-
TACGCCATTCT-3', 5'-CCACGGAGTGCAGCACATAC-3';
Ero1 L, 5'-AAACCCTGCCATTCTGATGAA-3', 5'-ACTCATC-
CACGGCTCCAA GT-3'; Ero1 beta, 5'-TGATTCGCAGGAC-
CACTTTTG-3', 5'-TAGCCAGTGTACCGTTCCGG-3';
Herpud1, 5'-CCCACCTGAGCCGAGTCTAC-3', 5'-CTTGGA-
GACACTGGTGATCCAA-3'; ATF3, 5'-CCT ATGCAAAGCAG-
GATCCC-3', 5'-GCGTTGTCAGCCACAGTGG-3'; GRP94, 5'-
CTGGGTCAAGCAGAAAGGAG-3' 5'-TCTCTGTTGCTTC-
CCGACTT-3'; BiP, 5'-GCTTCGTGTCTCCTCCTGAC-3', 5'-
TAGGAGTCCAGCAACAGGCT-3'; Chop, 5'-CCAACAGAG-
GTCACACGCAC-3', 5'-TGACTGGAATCTGGAGAGCGA-3';
Xbp1-spliced, 5'-GAGTCCGCAGCAGGTG-3', 5'-GTGTCA-
GAGTCCATGGGA-3'; Xbp1-total, 5'-CACCTTCTTGCCTGCT-
GGAC-3', 5'-GGGAGCCCTCATATCCACAGT-3'. The rat
primer sequences were as follows: Actin, 5'-ATC CTG GCC
TCA CTG TCC AC-3', 5'-CTA GAA GCA TTT GCG GTG CA-
3';  GAPDH, 5'-CACCACCAACTGCTTAGCCC-3', 5'-
TGGCATGGACTGTGGTCATG-3'; Insulin I, 5'-CAGCAC-
CTTTGTGGTCCTCA-3', 5'-CCCACACACCAGGTACAGAGC-
3'; Insulin II, 5'-CTGCCCAGGCTTTTGTCAAA-3', 5'-CTTC-
CACCAAGTGAGAACCACA-3'; MafA, 5'-GGCACATTCT-
GGAGAGCGA-3', 5'-CCCGCCAACTTCTCGTATTTC-3'; Pdx-
1, 5'-CCACCAAAGCTCACGCGT-3', 5'-CTGCGTATGCAC-
CTCCTGC-3'; NeuroD, 5'-GCTTGAAGCCATGAATGCAG-3',
5'-TCCTCTCCCCCATTTCTCAGA-3'; ERp72, 5'-TCTAAC-
CAATCACCGGGCTG-3',5'-TCATGGTAAGGTGCCGAGG-3';
BiP, 5'-ACCCTTACTCGGGCCAAATT-3', 5'-AGAGCG-
GAACAGGTCCATGT-3'; ERp58, 5'-CGAAAACTTCGA-
GAGTCGCG-3', 5'-GCAAGCCTCTTGCAATGTCC-3'; ERp57,,
ERp72 and GRP78/BiP protein are elevated and ERp72 oxi- dized state is increased in AdDNPerk 832/13 beta cells Figure 8
ERp72 and GRP78/BiP protein are elevated and 
ERp72 oxidized state is increased in AdDNPerk 832/13 
beta cells. A. Triplicate samples were probed with antibod-
ies to ERp72, ERp57, BiP and actin, which served as the load-
ing control. B. ERp72 expression was increased in islets from 
P2 Perk KO mice. Samples are from duplicate mice for each 
genotype. C. At 24 hr or 36 hr post-transduction, protein 
samples were isolated and treated with AMS to differentiate 
the reduced and oxidized forms of ERp72 and ERp57 on 
PAGE gels. Western blots showed increased oxidized iso-
forms of both ERp72 and ERp57 in 832/13 cells infected with 
AdDNPerk compared to cells infected with AdLacZ.BMC Cell Biology 2009, 10:61 http://www.biomedcentral.com/1471-2121/10/61
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5'-GGACTCAAG CGAAGTGACGG-3'; 5'-TCTGCTGCCAG-
CAAGAACTG-3'; Ero1 L, 5'-TTCACTGAGGAGGGCGGTT-3',
5'-CAGGACGGTCACTGCAATCA-3'; Ero1 beta, 5'-GTGCTTT-
GTCAAAGGTGG CC3'; 5'-GCAGAAGGGTCTTGGTGTCAG-
3'; Crebpp1, 5'-ACGCCGGAGTCAATTCCTATC-3', 5'-
GAGCTGATGTTGCGG GAAGA-3'; Psma5, 5'-TCACAC-
CCCTGTCGTACTCG-3', 5'-TTTCAGTCGTGTGGCCTTTG-3';
Sec61a, 5'-GCTTCTGAATTT CCGGCAAG-3', 5'-AGGCAG-
GGAGTGTAGTCGGAC-3'; Sec63, 5'-TGGGTGAGTGAGAC-
CTTCCC-3', 5'-AACCCCGGATCTTCCCAGTA-3'; Der1, 5'-
CACCAGCCATGCTAAGCAGA-3', 5'-TCAGTGTGGGTCAG-
GTCCAAG-3'; Herpud1, 5'-GTGCTCTGTTGCTGGAGGCT-3',
5'-AGCACATCGTCATCCTGTGG-3'; Xbp-1 spliced, 5'-
CTGAGTCCGAATCAGGTGCAG-3', 5'-ATCCATGGGAAGAT-
GTTCTGG-3'; Xbp-1 total, 5'-CCCTTCTCCCTTCAGCGAC-3',
5'-CGTTGGCAAAAGTGTCCTCC-3'; Rat cyclin D2, 5'-TGCT-
GACCAAGATCACCCAC-3', 5'-CCTGGCAGGCTTTGA-
GACAA-3'; Rat cyclin B2, 5'-GCCCCTGAGGATGTCTCCAT-
3', 5'-AGAGAAAGCTTGGCAGAGGCT-3'; Rat cyclin A2, 5'-
AGTGTGAAGATGCCCTGGCT-3', 5'-TGGCTCCGGGTAAA-
GAGACA-3'; Rat cyclin E, 5'-GTCGCAGGGTTGCTGTTGAT-
3', 5'-CATGCTTGCTCACGACCACT-3'
Western blots
Total 832/13 cellular protein was extracted with RIPA
buffer (1% Nonidet P40, 0.5% sodium doxycholate, 0.1%
SDS, 1 × PBS, pH 8.0) containing 1× protease and phos-
phatase inhibitor cocktails (Sigma, Inc.) Protein expres-
sion was assayed by Western blots. Primary antibodies
used in the analysis were: ERp72 (1:2500, Stressgen, Inc),
GRP78/BiP (1:500, Santa Cruz, Inc), ERp57 (1:300, Santa
Cruz), and anti-GFP (Sigma, Inc.) to detect EFYP-ATF6.
For Western blots performed on islets from single mice,
60 islets from each mouse were dissolved in 2× SDS sam-
ple buffer and then loaded onto a 4-15% gradient gel.
Protein synthesis
After 16 or 24 hr post-transduction, 832/13 cells were
deprived of methionine and cysteine (Met/Cys) for 30
minutes at 37°C in Met/Cys-free DMEM, 10% dialyzed
FBS. The cells were then labeled with [35S] Met/Cys (500
μCi/ml) at 37°C for 0, 15, 30 minutes, and the reactions
were stopped by the addition of concentrated non-radio-
active Met/Cys solution (0.1 M each). After two washes
with PBS, the cells were lysed in RIPA buffer and then total
cellular protein was precipitated with 10% trichloroacetic
acid (TCA). The precipitates were washed with 20% ice-
cold acetone, air-dried for 20 minutes and then dissolved
in 30 mM Tris, 7 M urea, 2 M thiourea, and 4% CHAPS.
The resident radioactivity was measured by scintillation
counting and normalized to total protein content.
Immunohistochemistry
Paraffin-embedded sections or cryo-sections were sub-
jected to immunohistochemistry using the following pri-
mary antibodies: ERp72 (1:1000, Stressgen), insulin
(1:500, Linco Research); proinsulin (1:1000, Ole D. Mad-
sen, Beta Cell Biology Consortium); GRP78/BiP (1:500,
Santa Cruz). Appropriate secondary antibodies conju-
gated with Alexa Fluor350, 488 or 555 dye (Molecular
Probes) were used to visualize the labeled cells. Fluores-
cence images were captured and analyzed with a Nikon
Eclipse E1000 and Image-Pro Plus (Phase 3 Imaging Sys-
tems, GE Healthcare, Inc.).
Determination of the oxidative state of ERp72 and ERp57
At 24 hours post-transfection, the medium was removed,
and the cells were briefly washed with ice cold PBS and
lysed at 0°C for 5 min in 20% formic acid/2% SDS. Cell
lysate proteins were precipitated with 10% TCA. Precipi-
tates were washed twice with ice cold 70% acetone. The
TCA precipitates were resuspended in 80 mM Tris-HCl pH
6.8, 2% SDS, supplemented with a cocktail of protease
inhibitors with or without 10 mM 4-acetamido-4'-male-
imidylstilbene-2,2'-disulfonic acid (AMS, Molecular
Probes, Inc.). After incubating for 30 min at room temper-
ature and then for 10 min at 37°C, samples were sub-
jected to non-reducing SDS-PAGE followed by western
blot analysis to detect ERp72 and ERp57. Non-transfected
cells were treated with 10 mM DTT or 5 mM diamide for
10 min at 37°C as reduced and oxidized controls.
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